Table 7 Univariate and multivariate analyses of prognostic factors for overall survival
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
N | 10-year LRRFS (%)(IC 95%) | P | RR (IC 95%) | P | RR (IC 95%) | |
Age (continuous variable) | 0.7 | 1.0 (0.99–1.02) | ||||
Age (dummy variable) | 0.11 | |||||
 >40 | 597 | 67 (63–72) | 1 | |||
 ⩽40 | 153 | 60 (52–69) | 1.3 (0.9–1.7) | |||
Menopause a | 0.22 | |||||
 No | 563 | 67 (63–72) | 1 | |||
 Yes | 187 | 63 (55–71) | 1.2 (0.9–1.6) | |||
Clinical tumour stage a | 0.005 | |||||
 cT2 | 556 | 68 (64–73) | 1 | |||
 cT3 | 194 | 59 (51–67) | 1.5 (1.1–1.9) | |||
Clinical nodal status a | <10−7 | <10−3 | ||||
 cN0 | 465 | 73 (69–78) | 1 | 1 | ||
 cN1 | 285 | 54 (48–61) | 2.0 (1.6–2.6) | 2.1 (1.6–2.7) | ||
Histological type | 0.44 | |||||
 Ductal | 672 | 65 (61–69) | 1 | |||
 Lobular | 78 | 72 (62–84) | 0.8 (0.6–1.3) | |||
Hormonal receptors (HR) a | <10−7 | <10−3 | ||||
 HR+ | 466 | 70 (66–75) | 1 | 1 | ||
 HR− | 166 | 49 (42–58) | 2.2 (1.7–2.8) | 2.4 (1.8–3.2) | ||
Histological grade a , b | 0.0004 | 0.02 | ||||
 Grade 1 | 114 | 78 (69–87) | 1 | 1 | ||
 Grade 2 | 362 | 66 (61–71) | 1.8 (1.1–2.8) | 1.8 (1.1–2.8) | ||
 Grade 3 | 217 | 58 (51–66) | 2.5 (1.6–3.9) | 1.9 (1.2–3.1) | ||
Mitotic index a | <10−4 | |||||
 Grade 1 | 182 | 77 (70–85) | 1 | |||
 Grade 2 | 189 | 67 (60–74) | 1.6 (1.1–2.4) | |||
 Grade 3 | 297 | 59 (53–65) | 2.2 (1.5–3.2) | |||
Clinical response a | 0.15 | 0.003 | ||||
 ⩾50% | 434 | 67 (63–73) | 1 | 1 | ||
 <50% | 309 | 64 (58–70) | 1.2 (0.9–1.6) | 1.5 (1.2–2.0) |